BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22894587)

  • 21. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
    Kirshner HS
    Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
    Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
    Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence based cardiology: Prevention of ischaemic stroke.
    Barnett HJ; Eliasziw M; Meldrum HE
    BMJ; 1999 Jun; 318(7197):1539-43. PubMed ID: 10356014
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral anticoagulants and non-cardioembolic stroke prevention.
    Schachter ME; Tran HA; Anand SS
    Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient ischemic attack: reviewing the evolution of the definition, diagnosis, risk stratification, and management for the emergency physician.
    Siket MS; Edlow JA
    Emerg Med Clin North Am; 2012 Aug; 30(3):745-70. PubMed ID: 22974647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network meta-analysis of antiplatelet treatments for secondary stroke prevention.
    Baumgartner RW
    Eur Heart J; 2008 May; 29(9):1082-3. PubMed ID: 18359758
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of a perindopril-based blood-pressure-lowering regimen in patients with previous stroke or transient ischaemic attack (progress). How do the results affect practice in Pakistan?
    Khan M; Kamal AK
    J Pak Med Assoc; 2010 Jul; 60(7):597-8. PubMed ID: 20578620
    [No Abstract]   [Full Text] [Related]  

  • 29. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
    Diener HC; Weber R; Weimar C; Röther J
    Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Secondary prevention after stroke: healthy life style, oral anticoagulation].
    Audebert H; Haberl RL
    MMW Fortschr Med; 2003 May; 145 Suppl 2():61-4. PubMed ID: 14579487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter by Borja and Garcia-Rafanell regarding article, "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association".
    Borja J; García-Rafanell J
    Stroke; 2011 Jun; 42(6):e388; author reply e386. PubMed ID: 21546474
    [No Abstract]   [Full Text] [Related]  

  • 32. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet agents for stroke prevention following transient ischemic attack.
    Weinberger J
    South Med J; 2008 Jan; 101(1):70-8. PubMed ID: 18176296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The final SAMMPRIS results: a review.
    Chen S; Hanel RA
    World Neurosurg; 2014; 82(1-2):5-6. PubMed ID: 24768709
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry.
    Touzé E; Mas JL; Röther J; Goto S; Hirsch AT; Ikeda Y; Liau CS; Ohman EM; Richard AJ; Wilson PW; Steg PG; Bhatt DL;
    Stroke; 2006 Dec; 37(12):2880-5. PubMed ID: 17068303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke prevention.
    Lip GY; Rothwell P; Sudlow C
    Clin Evid; 2004 Dec; (12):253-84. PubMed ID: 15865638
    [No Abstract]   [Full Text] [Related]  

  • 37. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy.
    Swartz RH; Ladhani NNN; Foley N; Nerenberg K; Bal S; Barrett J; Bushnell C; Chan WS; Chari R; Dowlatshahi D; Amrani ME; Gandhi S; Gubitz G; Hill MD; James A; Jeerakathil T; Jin A; Kirton A; Lanthier S; Lausman A; Leffert LR; Mandzia J; Menon B; Pikula A; Poppe A; Potts J; Ray J; Saposnik G; Sharma M; Smith EE; Bhogal S; Smitko E; Lindsay MP;
    Int J Stroke; 2018 Jun; 13(4):406-419. PubMed ID: 29171360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice. Transient ischemic attack.
    Johnston SC
    N Engl J Med; 2002 Nov; 347(21):1687-92. PubMed ID: 12444184
    [No Abstract]   [Full Text] [Related]  

  • 39. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.